Navigation Links
NHS National Innovation Centre Cites VNUS Closure(R) Procedure as Select Innovative Technology
Date:4/3/2009

Minimally Invasive Treatment for Varicose Veins to be showcased at National Health Service EXPO

SAN JOSE, Calif., April 3 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, today announced that the UK NHS National Innovation Centre has identified the VNUS Closure(R) procedure as a select innovative technology that is bringing benefits to National Health Service (NHS) hospitals and patients. The VNUS Closure procedure is a minimally invasive treatment for patients suffering with symptomatic varicose veins and venous reflux, and has been demonstrated in numerous comparative studies to offer advantages over conventional vein stripping surgery. The technique will be showcased at the NHS EXPO Meeting on June 18-19, 2009.

"Our treatment alternative has enabled many NHS Trusts to perform a very common operation virtually pain-free in a simple treatment room in around 30-40 minutes without a general anaesthetic or overnight stay," said Michael Branagan-Harris, UK Managing Director for VNUS Medical Technologies UK Ltd. "This in turn has enabled hospitals to save money by freeing up expensive resources such as operating theatres, ward beds and staff for more invasive procedures."

"It is clear that by freeing up hospital operating theatres and reducing both treatment and recovery times, this technique offers significant benefits for both the patient and the NHS," said Mr. Brian Winn, Head of Technology & Product Innovation at the NHS National Innovation Centre.

"In my view the VNUS Closure procedure is the preferred technique to treat venous reflux because it requires no special modifications to operating areas, is well tolerated by patients, requires minimal post-procedure analgesia and is highly effective at permanently closing the vein," said Ian Franklin, Consultant Vascular Surgeon from Charing Cross NHS Hospital & Imperial College London.

Varicose veins are caused by increased pressure in the legs as a result of venous reflux and faulty valves in the leg veins. Left untreated, venous reflux can lead to painful varicose veins, swelling in the lower limbs, and skin problems, such as itching, redness, eczema, and leg ulcers.

For the past century, the traditional treatment for varicose veins has been a technique called vein stripping, which is carried out under general anaesthesia in operating theatres, and sometimes involves an overnight stay in a hospital bed. This treatment involves a groin incision and the complete removal of the saphenous vein, and recovery can be lengthy and uncomfortable. Surgeons in the NHS perform around 37,000 varicose vein stripping procedures every year.

The VNUS Closure procedure consists of inserting a thin radiofrequency (RF) catheter into the diseased vein through a small incision. The catheter then heats the diseased vein sequentially in 7-centimeter segments, sealing it from the inside and effectively closing it down. Blood returning to the heart then naturally reroutes through healthy veins containing normal valves.

"We are delighted that the NHS National Innovation Centre is showcasing our technology at the forthcoming EXPO meeting, and appreciate their support in driving the acceptance and adoption of our innovative treatment through NHS Hospitals across the UK," said Brian Farley, President and CEO of VNUS Medical Technologies, Inc. "With the support of the NHS, Charing Cross NHS Hospital in London and Ian Franklin, we are continuing our programs to train more surgeons in the VNUS Closure procedure so that more UK patients can benefit from this proven technology."

Additional information about the VNUS Closure Procedure can be found at www.vnus.com. To learn more about the NHS National Innovation Centre please visit www.nic.nhs.uk.

ABOUT VNUS MEDICAL TECHNOLOGIES, INC.

Founded in 1995 and headquartered in San Jose, California, VNUS Medical Technologies (NASDAQ: VNUS) is a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease.


'/>"/>
SOURCE VNUS Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research
2. Mayo Clinic: Retired National Football League Linemen Have High Incidence of Sleep Apnea
3. DaVita Abstracts Accepted Into National Kidney Foundations 2009 Spring Symposium
4. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
5. Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
6. Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009
7. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
8. VIDEO from Medialink and International HIFU: New Prostate Cancer Procedure Being Tested in US Clinical Trials
9. Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients
10. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
11. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... 2017  Semler Scientific, Inc. (OTCQB: SMLR), an ... improve the clinical effectiveness and efficiency of healthcare ... quarter ended March 31, 2017. ... to identify when preventive care options are appropriate, ... heart attacks or strokes occur," said Doug ...
(Date:5/6/2017)... SKANEATELES FALLS, N.Y. , May 5, 2017 /PRNewswire/ ... expansion that will add approximately 100,000 square feet to ... announced in September 2016 its commitment to bring more ... York , where Welch Allyn has maintained a ... facility will help accommodate these new positions, a large ...
(Date:5/4/2017)... Israel , May 4, 2017  DarioHealth Corp. ... mobile health and big data solutions, today announced that ... A&D Company, and STI Technologies Limited to lower diabetes ... immediately. Through STI,s innoviCares card, which is available throughout ... , DarioHealth customers will be eligible for additional savings ...
Breaking Medicine Technology:
(Date:5/24/2017)... ... May 24, 2017 , ... Adelberg-Montalvan ... dentistry options for its patients on Long Island, New York. , Holistic ... being, and is one of the biggest trends in dentistry today. , ...
(Date:5/24/2017)... ... May 24, 2017 , ... The CFOs included on ... health systems in the nation and help their organizations navigate the challenges in ... been instrumental in developing successful hospital and health system strategy. , Becker's Hospital ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... Technique, technique, ... back injury when either lifting weights for strength training and exercise or simply lifting ... Center . , “Body position is everything,” Dr. Chang says. “Improper technique in lifting ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a ... today that its iClinic V12.2 solution has achieved approval from National Center for ... PCMH 2017 standards which emphasize team-based care with a significant focus on the ...
(Date:5/23/2017)... PITTSBURGH, Pa. (PRWEB) , ... May 23, 2017 , ... ... today plans to open The Alexis Joy D’Achille Center for Women’s Behavioral Health at ... state-of-the-art care available in western Pennsylvania for women suffering from pregnancy-related depression. Construction ...
Breaking Medicine News(10 mins):